-
-
Member
Aroa Half Year Results (26 November 2020) - https://wcsecure.weblink.com.au/pdf/ARX/02313882.pdf
2020 2019
Total revenue 9,180 13,165
Gross profit 6,035 10,108
Gross margin % 66% 77%
Total normalised operating expenses (11,354) (9,506)
Normalised EBIT (3,450) 1,082
Normalised EBITDA (2,316) 2,153
-
Good that they remove that $9m+ of other losses to get from the actual to a more palatable normalised number.
But it is a one off.
Still looks promising to me but not betting the wine cellar on it.
-
Member
Agree. Niche products and still early stage. I plan to accumulate small parcels from time to time by the price. Cheers.
-
Member
ASX ANNOUNCEMENT/MEDIA RELEASE
16 DECEMBER 2020
NEW STUDY SHOWS AROA BIOSURGERY’S MYRIADTM EFFICACY IN HEALING EXPOSED VITAL BODY STRUCTURES
HIGHLIGHTS
• Aroa’s Myriad™ is further validated in a clinical study and peer-reviewed publication - Journal of Wound Care.
• Study shows 100% success rates from use of Myriad™ when patients underwent surgical reconstruction of exposed vital structures such as bone and tendon.
• Demonstrates utility of Myriad™ for both implant procedures and dermal reconstruction and across a wide range of surgical procedures.
• All patients in the study healed well with a zero rate of complications.
-
-
Member
-
Originally Posted by Snow Leopard
I have some .
I have none.
-
-
Originally Posted by RupertBear
Geez I wish I didnt have any
Well that can be easily fixed as from 10am Sydney time tomorrow.
But depending upon what kind of investor/trader you are
and what exit conditions you set when you bought
and where, objectively, you see the balance of future risk verses reward over you timeframe of choice
and etc;
decides where you go.
Hope it turns round for you.
Last edited by Snow Leopard; 27-01-2021 at 10:09 PM.
Reason: removed superfluous quote
om mani peme hum
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks